Thrombosis
From the Journals
Cardiovascular disease risk unchanged in men with hemophilia A
Concerns about an elevated cardiovascular disease risk in hemophilia A patients may be unfounded, a new study suggests.
From the Journals
Line complications plague dose-adjusted EPOCH-R in non-Hodgkin lymphoma
The risk of line-associated complications was significantly higher with dose-adjusted EPOCH-R therapy, compared with R-CHOP, in patients with...
News
Canada approves Jivi for hemophilia A
Health Canada has approved Jivi® (antihemophilic factor [recombinant, B-domain deleted, PEGylated]) for use in patients with hemophilia A. Jivi (...
News
SNPs linked to bleeding in African Americans on warfarin
Researchers say they have identified single-nucleotide polymorphisms (SNPs) that are associated with increased bleeding risk in African-American...
From the Journals
VTE risk may be high throughout disease course in uterine serous carcinoma
The risk was highest in women with cardiovascular disease, hypertension, and stage III and IV disease.
News
Inhibitor receives orphan designation for ITP
The U.S.
News
CHMP recommends change for eptacog alfa
The European Medicine’s Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the terms of the marketing...
News
CTPA overused in veterans with suspected PE
SAN ANTONIO—The recommended approach to evaluating suspected pulmonary embolism (PE) is “greatly underutilized” in the Veterans Health...
News
Obese PE patients have lower risk of death
SAN ANTONIO—Patients with pulmonary embolism (PE) have a lower mortality risk if they are obese, according to a retrospective analysis of nearly 2...
Conference Coverage
Be proactive with prophylaxis to tame VTE
Dr. Jeffrey Weitz offers seven steps to improve prophylaxis in the hospital.
News
Rivaroxaban gains indication for prevention of major cardiovascular events in CAD/PAD
Rivaroxaban (Xarelto) is the first direct oral anticoagulant to gain an indication for prevention of cardiovascular events.